Clinical Trials Directory

Trials / Completed

CompletedNCT01313156

LUPS-Lipids and Glucose Under Prospective Surveillance

Lipids and Glucose Under Prospective Surveillance

Status
Completed
Phase
Study type
Observational
Enrollment
1,962 (actual)
Sponsor
Asklepios proresearch · Industry
Sex
All
Age
25 Years – 60 Years
Healthy volunteers
Accepted

Summary

Prospective, non-randomized cohort study to analyse genetic variations, dietary patterns, perceived stress and anxiety and early changes in lipid metabolism leading to the metabolic syndrome and type 2 diabetes

Detailed description

The LUPS-study is a collaboration between Asklepios Clinics Hamburg GmbH and University Clinic Hamburg Eppendorf, Germany. This study is assessing a multitude of serum biomarkers, anthropometrics, dietary habits, physical activity, perceived stress along with genetic information from "healthy workers" (25-60years) to better understand phenotype-genotype associations leading to MetS and type 2 diabetes.

Conditions

Timeline

Start date
2008-11-01
Primary completion
2019-08-01
Completion
2019-08-01
First posted
2011-03-11
Last updated
2019-08-09

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01313156. Inclusion in this directory is not an endorsement.

LUPS-Lipids and Glucose Under Prospective Surveillance (NCT01313156) · Clinical Trials Directory